Nemours Children’s Health director of preventive cardiology Dr. Carissa Baker-Smith stated in a recent interview that disrupted and poor sleep in children could be linked to difficulty focusing in the daytime. This, she added, could negatively affect their performance in school.
Sleep apnea is a sleeping disorder known to cause serious health problems. When untreated, sleep apnea causes an individual’s breathing to stop repeatedly while they’re sleeping. This, in turn, causes loud snoring and fatigue in the daytime, despite having a full night’s sleep.
The main types of sleep apnea are:
Central sleep apnea
This occurs when an individual’s brain doesn’t send the correct signals to the muscles that control breathing, thereby triggering intermittent breathing.
Obstructive sleep apnea
This is the most common type of apnea and occurs when an individual’s throat muscles relax and air can’t flow freely when the person is asleep.
Complex sleep apnea syndrome
This occurs when an individual suffers from both central sleep apnea and obstructive sleep apnea.The disorder, which is common in teenagers and kids, may be linked to changes in heart structure and high blood pressure.
The American Heart Association notes that obstructive sleep apnea affects between 30%–60% of obese teenagers and up to 6% of all children. These disruptions in sleep have also been associated with abnormal lipids and insulin resistance and can also elevate blood pressure, which may be harmful to the children’s cardiovascular health when they’re older.
Teachers and parents are advised to remain alert and observe for any symptoms of obstructive sleep apnea in their children as this will allow for earlier diagnosis and treatment.
The most common symptoms of sleep apnea include:
The risk factors for obstructive sleep apnea in children include:
Parents or guardians who notice any of these symptoms should talk to their child’s pediatrician, who may refer the child to an otolaryngologist if their tonsils are enlarged. Resetting children’s bedtimes so that they can get the recommended hours of sleep every night may also be helpful.
Baker-Smith recommends that children aged 13 to 18 should sleep for 8 to 10 hours while those aged 6 to 12 should sleep for 9 to 12 hours. Additionally, kids aged between 2 to 5 should get between 10 to 13 hours of sleep while those under 2 years should sleep for 11 to 14 hours.
If sleep apnea is positively diagnosed, remedies can be of great help in addressing this condition which has the potential to trigger several other complications.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and…
While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…
Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…
The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…
As July came to an end, the United States reached an undesirable milestone: exceeding the…
Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…